Azitra, Inc. (AZTR) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Feb 27, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Azitra, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Azitra, Inc.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+38.29%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Positive
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Azitra, Inc. actually do?
Answer:
Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on developing precision dermatology therapies using genetically engineered proteins and live biotherapeutic products. The company leverages a proprietary platform that includes a microbial library of approximately 1,500 bacterial strains, augmented by AI/machine learning and licensed genetic engineering technology. Azitra's initial focus is on genetically engineered strains of Staphylococcus epidermidis, with lead programs targeting Netherton syndrome (ATR-12) and EGFR inhibitor-associated rash in cancer patients (ATR-04). The company also has a program for ichthyosis vulgaris (ATR-01) and is exploring partnerships and expanding its platform for broader dermatological applications.
Question:
What are Azitra, Inc.'s revenue drivers?
Answer:
As an early-stage company, Azitra has not commenced commercial operations and currently generates no revenue from product sales. Future revenue is expected to be driven by the successful development and commercialization of its product candidates.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required